Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Hyperactivity, Motor

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Hyperactivity, Motor in 7 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Research Excerpts

ExcerptRelevanceReference
"Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia."7.78Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012)
"Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia."3.78Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, G1
Cheng, J1
McCorvy, JD1
Lorello, PJ1
Caldarone, BJ1
Roth, BL1
Kozikowski, AP1
Rogóż, Z1
Fox, MA1
Panessiti, MG1
Hall, FS1
Uhl, GR1
Murphy, DL1
Pałucha-Poniewiera, A1
Kłodzińska, A1
Stachowicz, K1
Tokarski, K1
Hess, G1
Schann, S1
Frauli, M1
Neuville, P1
Pilc, A1
McFarland, K1
Price, DL1
Bonhaus, DW1
Filip, M1
Bubar, MJ1
Cunningham, KA1
Siuciak, JA1
Chapin, DS1
McCarthy, SA1
Guanowsky, V1
Brown, J1
Chiang, P1
Marala, R1
Patterson, T1
Seymour, PA1
Swick, A1
Iredale, PA1

Other Studies

7 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Hyperactivity, Motor

ArticleYear
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.
    Journal of medicinal chemistry, 2017, 07-27, Volume: 60, Issue:14

    Topics: Animals; Antipsychotic Agents; Benzylamines; beta-Arrestins; Cyclopropanes; HEK293 Cells; Humans; Hy

2017
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:6

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, An

2012
An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
    Psychopharmacology, 2013, Volume: 227, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Autoreceptors; Brain; Compulsive Beha

2013
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
    Neuropharmacology, 2008, Volume: 55, Issue:4

    Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Cyclopentanes; Disease M

2008
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
    Behavioural pharmacology, 2011, Volume: 22, Issue:7

    Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System S

2011
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 310, Issue:3

    Topics: Amphetamines; Animals; Cocaine; Drug Interactions; Fluorobenzenes; Hyperkinesis; Indoles; Male; Phen

2004
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
    Neuropharmacology, 2007, Volume: 52, Issue:2

    Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextro

2007